We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.64%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$1.2B
AUM Growth
-$56.7M
(-4.5%)
Cap. Flow
-$118M
Cap. Flow
% of AUM
-9.87%
Top 10 Holdings %
Top 10 Hldgs %
47.76%
Holding
41
New
7
Increased
14
Reduced
14
Closed
4
Top Buys
| 1 |
Goldman Sachs
GS
|
+$55M |
| 2 |
JPMorgan Chase
JPM
|
+$55M |
| 3 |
Gilead Sciences
GILD
|
+$5.67M |
| 4 |
iShares US Financial Services ETF
IYG
|
+$4.05M |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$3.78M |
Top Sells
| 1 |
Comcast
CMCSA
|
+$62.7M |
| 2 |
CVS Health
CVS
|
+$52.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$26.3M |
| 4 |
Adobe
ADBE
|
+$17.7M |
| 5 |
Apple
AAPL
|
+$17.5M |
Sector Composition
| 1 | Healthcare | 32.43% |
| 2 | Financials | 18.4% |
| 3 | Technology | 14.48% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Communication Services | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Starbucks
SBUX
$124B
| $58.4M | 4.88% |
999,534
-14,013
| -1% | -$793K |
|
|
2
Adobe
ADBE
$93.5B
| $58.1M | 4.86% |
446,798
-151,224
| -25% | -$17.7M |
|
|
3
Apple
AAPL
$4.89T
| $57.7M | 4.82% |
1,607,792
-530,144
| -25% | -$17.5M |
|
4
Microsoft
MSFT
$2.98T
| $57.4M | 4.79% |
871,340
-116,696
| -12% | -$7.48M |
|
5
TJX Companies
TJX
$171B
| $57M | 4.76% |
1,441,764
-161,718
| -10% | -$6.23M |
|
6
Walt Disney
DIS
$173B
| $56.9M | 4.75% |
501,566
-129,755
| -21% | -$14.3M |
|
|
AGN
7
DELISTED
Allergan plc
AGN
| $56.6M | 4.73% |
236,954
+6,614
| +3% | +$1.54M |
|
8
Mastercard
MA
$487B
| $56.6M | 4.73% |
503,176
-95,079
| -16% | -$10.4M |
|
9
PayPal
PYPL
$50B
| $56.6M | 4.73% |
1,315,275
-186,065
| -12% | -$7.78M |
|
10
Kroger
KR
$35.9B
| $56.4M | 4.71% |
1,911,140
+94,594
| +5% | +$3.02M |
|
11
Biogen
BIIB
$30.8B
| $56M | 4.68% |
204,754
+8,395
| +4% | +$2.37M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $55.7M | 4.65% |
447,614
-109,932
| -20% | -$13.2M |
|
13
Alphabet (Google) Class A
GOOGL
$4.33T
| $55.5M | 4.64% |
1,308,900
-187,680
| -13% | -$7.89M |
|
14
Medtronic
MDT
$107B
| $55.4M | 4.63% |
687,992
+47,533
| +7% | +$3.71M |
|
|
15
Gilead Sciences
GILD
$169B
| $55.4M | 4.63% |
815,718
+80,685
| +11% | +$5.67M |
|
16
Kraft Heinz
KHC
$31.1B
| $55.4M | 4.63% |
610,070
-55,268
| -8% | -$4.98M |
|
17
UnitedHealth
UNH
$384B
| $54.9M | 4.58% |
334,586
-97,685
| -23% | -$16M |
|
|
18
JPMorgan Chase
JPM
$912B
| $54.7M | 4.57% |
+623,103
| New | +$55M |
|
19
Bristol-Myers Squibb
BMY
$124B
| $54.2M | 4.53% |
996,471
+21,116
| +2% | +$1.16M |
|
|
20
Goldman Sachs
GS
$323B
| $52.3M | 4.37% |
+227,666
| New | +$55M |
|
|
21
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
| $13.7M | 1.14% |
286,203
+81,100
| +40% | +$3.78M |
|
22
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $12.1M | 1.01% |
455,496
+112,332
| +33% | +$2.9M |
|
23
State Street Health Care Select Sector SPDR ETF
XLV
$41.4B
| $12.1M | 1.01% |
162,195
+23,035
| +17% | +$1.68M |
|
24
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
| $8.44M | 0.71% |
191,922
+55,514
| +41% | +$2.38M |
|
25
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.5B
| $5.97M | 0.5% |
194,948
+57,919
| +42% | +$1.77M |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, WestEnd Advisors held 41 positions worth $1.2B, down 4.5% from $1.25B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
WestEnd Advisors withdrew a net $118M in Q1 2017, closing 4 positions and reducing 14 holdings. Its most notable exit was Comcast, an estimated $62.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 36% a quarter earlier, followed by Financials and Technology.
Against the trend, WestEnd Advisors opened a new position in Goldman Sachs worth $52.3M.
- WestEnd Advisors's largest Q1 2017 buy was Goldman Sachs: 227,666 shares worth $52.3M.
- WestEnd Advisors added most to Gilead Sciences in Q1 2017, an estimated $5.67M increase.
- WestEnd Advisors's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $26.3M.
- WestEnd Advisors fully exited Comcast in Q1 2017, selling an estimated $62.7M.
- WestEnd Advisors's ten largest holdings make up 48% of its $1.2B portfolio in Q1 2017.
- WestEnd Advisors opened 7 new positions and closed 4 in Q1 2017.
- WestEnd Advisors's portfolio value fell 4.5% quarter-over-quarter to $1.2B.
Based on WestEnd Advisors's 13F filing for Q1 2017, filed 26 Apr 2017.